Alpha Cognition (ACOG) Competitors $5.88 -0.21 (-3.45%) As of 01/14/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends ACOG vs. ORGO, AURA, KALV, ETON, PRME, VALN, KRRO, ENGN, GLUE, and RGNXShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Organogenesis (ORGO), Aura Biosciences (AURA), KalVista Pharmaceuticals (KALV), Eton Pharmaceuticals (ETON), Prime Medicine (PRME), Valneva (VALN), Korro Bio (KRRO), enGene (ENGN), Monte Rosa Therapeutics (GLUE), and REGENXBIO (RGNX). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Organogenesis Aura Biosciences KalVista Pharmaceuticals Eton Pharmaceuticals Prime Medicine Valneva Korro Bio enGene Monte Rosa Therapeutics REGENXBIO Organogenesis (NASDAQ:ORGO) and Alpha Cognition (NASDAQ:ACOG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk. Is ORGO or ACOG more profitable? Alpha Cognition has a net margin of 0.00% compared to Organogenesis' net margin of -1.62%. Alpha Cognition's return on equity of 0.00% beat Organogenesis' return on equity.Company Net Margins Return on Equity Return on Assets Organogenesis-1.62% -2.69% -1.63% Alpha Cognition N/A N/A N/A Does the media favor ORGO or ACOG? In the previous week, Organogenesis and Organogenesis both had 2 articles in the media. Alpha Cognition's average media sentiment score of 1.87 beat Organogenesis' score of 1.01 indicating that Alpha Cognition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organogenesis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Cognition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer ORGO or ACOG? Organogenesis presently has a consensus target price of $5.00, indicating a potential upside of 73.01%. Given Organogenesis' stronger consensus rating and higher probable upside, analysts plainly believe Organogenesis is more favorable than Alpha Cognition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organogenesis 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in ORGO or ACOG? Organogenesis received 97 more outperform votes than Alpha Cognition when rated by MarketBeat users. CompanyUnderperformOutperformOrganogenesisOutperform Votes9766.44% Underperform Votes4933.56% Alpha CognitionN/AN/A Which has more volatility & risk, ORGO or ACOG? Organogenesis has a beta of 1.77, suggesting that its stock price is 77% more volatile than the S&P 500. Comparatively, Alpha Cognition has a beta of 2.54, suggesting that its stock price is 154% more volatile than the S&P 500. Do institutionals & insiders believe in ORGO or ACOG? 49.6% of Organogenesis shares are owned by institutional investors. 36.9% of Organogenesis shares are owned by insiders. Comparatively, 31.5% of Alpha Cognition shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings & valuation, ORGO or ACOG? Organogenesis has higher revenue and earnings than Alpha Cognition. Organogenesis is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganogenesis$455.04M0.80$4.95M-$0.06-48.17Alpha CognitionN/AN/AN/A-$2.56-2.30 SummaryOrganogenesis beats Alpha Cognition on 8 of the 14 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionBiological Products, Except Diagnostic Substances IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$94.58M$94.58M$2.14B$8.80BDividend YieldN/AN/A2.65%4.00%P/E Ratio-2.30N/A27.0016.97Price / SalesN/AN/A82.76118.05Price / CashN/AN/AN/A37.77Price / BookN/AN/A1.954.89Net IncomeN/AN/A$165.18M$228.40M7 Day Performance2.80%2.80%-1.12%-3.68%1 Month PerformanceN/AN/A-2.30%0.03%1 Year PerformanceN/AN/A5.08%13.82% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha CognitionN/A$5.88-3.4%N/AN/A$94.58MN/A-2.30N/APositive NewsGap UpORGOOrganogenesis4.5421 of 5 stars$3.00-0.3%$5.00+66.7%-26.2%$377.18M$455.04M-50.00950Positive NewsAURAAura Biosciences2.1369 of 5 stars$7.50-1.3%$23.00+206.7%-9.7%$374.63MN/A-4.3450Short Interest ↑Positive NewsKALVKalVista Pharmaceuticals4.2925 of 5 stars$7.52-4.2%$25.00+232.4%-42.9%$371.62MN/A-2.07150ETONEton Pharmaceuticals3.2444 of 5 stars$14.00+4.2%$18.67+33.3%+207.1%$364.71M$34.68M-63.6420Short Interest ↓Analyst RevisionPRMEPrime Medicine3.4286 of 5 stars$2.77-5.8%$12.67+357.3%-66.2%$363.32M$800,000.00-1.35234Analyst UpgradeNews CoverageVALNValneva2.9006 of 5 stars$4.44-2.2%$18.50+316.7%-54.4%$360.80M$158.54M-34.15700Short Interest ↓Positive NewsKRROKorro Bio2.2907 of 5 stars$38.15+8.2%$144.00+277.5%-20.7%$357.39M$14.07M0.0070Short Interest ↑ENGNenGene2.3569 of 5 stars$8.06+5.9%$29.78+269.5%-3.4%$356.38MN/A-13.9031Short Interest ↑GLUEMonte Rosa Therapeutics2.3563 of 5 stars$5.66-0.7%$14.00+147.3%-7.3%$347.73M$14.98M-3.0990Short Interest ↑RGNXREGENXBIO4.4918 of 5 stars$6.95-7.5%$35.27+407.5%-53.4%$344.34M$84.33M-1.38370Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies ORGO Competitors AURA Competitors KALV Competitors ETON Competitors PRME Competitors VALN Competitors KRRO Competitors ENGN Competitors GLUE Competitors RGNX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACOG) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACOG Stock Alerts